Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting.
Phase of Trial: Phase III
Latest Information Update: 11 Aug 2010
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Cervical cancer; Human papillomavirus infections
- Focus Pharmacodynamics
- 01 Aug 2010 Results published in the Journal of Women's Health.
- 01 Aug 2010 Primary endpoint 'Geometric mean antibody titre' has been met, according to an article published in the Journal of Women's Health.
- 26 Feb 2010 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History